The pathogenetic role of Th17 cells in MS pathogenesis could be explained by their ability to transmigrate into CNS through the blood–brain barrier by expressing chemokine receptor 6 (CCR6 [CD196]) and producing IL-17 and IL-22 [29,30]. This evidence concerns the gene IL17A and myeloid sarcoma.